-
公开(公告)号:US20170226146A1
公开(公告)日:2017-08-10
申请号:US15427674
申请日:2017-02-08
申请人: John Y.L. Chung , Amude Kassim , John Limanto , Michael Shevlin , Peter E. Maligres , Daniel A. DiRocco , James F. Dropinski , Rose Mathew , Yi Ning Ji Chen , Edward C. Sherer , Mikhail Reibarkh , Artis Klapars , Alan Hyde , Susan L. Zultanski , Aaron Moment , Bryon Simmons , Tyler A. Davis , Timothy James Wright , Ralph Calabria , Louis Charles Campeau
发明人: John Y.L. Chung , Amude Kassim , John Limanto , Michael Shevlin , Peter E. Maligres , Daniel A. DiRocco , James F. Dropinski , Rose Mathew , Yi Ning Ji Chen , Edward C. Sherer , Mikhail Reibarkh , Artis Klapars , Alan Hyde , Susan L. Zultanski , Aaron Moment , Bryon Simmons , Tyler A. Davis , Timothy James Wright , Ralph Calabria , Louis Charles Campeau
IPC分类号: C07H19/10 , C07H19/24 , C07D487/04 , C07H19/06
CPC分类号: C07H19/10 , C07D487/04 , C07H19/06 , C07H19/24
摘要: The present invention is directed to a process for making Chloro-Substituted Nucleoside Phosphoramidate Compounds of formula (I): which are useful for the treatment and prophylaxis of HCV infection. The present invention is also directed to compounds that are useful as synthetic intermediates for making the compounds of formula (I).